Madison
79° F
Scattered Clouds
Scattered Clouds
Advertisement

Endoxifen shows promise as breast cancer treatment

Published On: Dec 17 2013 11:40:58 AM CST
Updated On: Jan 02 2014 02:03:52 PM CST
Cancer definition

iStock/firebrandphotography

By Mayo Clinic News Network

A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity. Mayo Clinic oncologist and lead author of the study Matthew Goetz, M.D., says, “We achieved up to sixtyfold higher levels of endoxifen compared to endoxifen levels achieved with the standard dose of tamoxifen. We have seen evidence for tumor regression in patients who had failed standard hormonal therapies including aromatase inhibitors, fulvestrant and tamoxifen. This is an exciting first step in the development of this drug.”

The findings indicate that Z-endoxifen, codeveloped by Mayo Clinic Cancer Center and the National Cancer Institute (NCI), may provide a new and better treatment for some women with estrogen positive breast cancer, and in particular for those who women who do not respond to tamoxifen and aromatase inhibitors. Results are being presented during the 2013 San Antonio Breast Cancer Symposium.

Source: http://newsnetwork.mayoclinic.org/discussion/endoxifen-shows-promise-as-breast-cancer-treatment

Advertisement
  • Join the Channel 3000 Street Team

    The Channel 3000 Street Team is made up of anyone who wants to hear about and contribute to community and breaking news.

  • Get your weather app

    Channel3000.com and WISC-TV3 deliver local forecasts, live radar, school closings and alerts for Madison and South Central Wisconsin to iOS or Android devices.

  • Learn more about WISC-TV

    Meet the News 3 staff, learn about our newscasts, search our job postings and find out how to contact us.

Advertisement